Skip to content

Achieve Life Sciences ACHV Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

AMB
Ambiq Micro, Inc.AMBQ
$3.01M
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$5.44M
TRV
Trevi Therapeutics, Inc.TRVI
$2.54M
Dakota Gold logo
Dakota GoldDC
$10.9M+572%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
Rigetti Computing, Inc. logo
Rigetti Computing, Inc.RGTI
$30K-92.7%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's proceeds from warrant exercises?
Achieve Life Sciences (ACHV) reported proceeds from warrant exercises of $21K in Q1 2026.
What does proceeds from warrant exercises mean?
Cash inflows generated from the exercise of outstanding warrants by investors to purchase common stock at a predetermined price. This represents a source of non-operating capital that strengthens the balance sheet and reduces the potential dilutive overhang of derivative securities.